Inflammation and Antioxidant Defenses Linked to Sleep Quality in Elderly, New Research Shows

A study published in BMC Geriatrics in February 2026 examines the relationship between inflammation, antioxidant defenses, and sleep quality in elderly populations. Researchers Liu, Yu, Hao, and their team conducted an investigation to explore biological factors contributing to sleep disturbances commonly experienced by older adults.

The study analyzed data from elderly participants to assess how inflammation and oxidative stress influence sleep. Researchers measured inflammatory biomarkers and antioxidant activity while evaluating participants' reported sleep quality. Results indicated that higher levels of inflammation were associated with poorer sleep outcomes, while stronger antioxidant defenses correlated with better sleep quality.

The researchers measured serum concentrations of proinflammatory markers including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP), all of which have been previously linked to altered sleep phenotypes. Elevated levels of these cytokines correlate with non-restorative sleep and increased wakefulness after sleep onset, phenomena frequently reported by the elderly. The study's data underscore a robust association between heightened inflammatory activity and poor sleep initiation and maintenance, suggesting that systemic inflammation may serve as both a biomarker and a mechanistic contributor to sleep dysfunction.

The authors examined total antioxidant capacity (TAC), a measure of the serum's collective ability to neutralize reactive oxygen species (ROS) and mitigate oxidative damage. Oxidative stress results from an imbalance between free radicals and antioxidant defenses and has been increasingly recognized as a key factor in aging and neurodegeneration. Low TAC levels were linked with fragmented sleep and reduced sleep efficiency, indicating that a diminished antioxidative defense renders the elderly more vulnerable to the deleterious effects of oxidative stress on neural circuits involved in sleep regulation.

While inflammation actively disrupts sleep patterns, insufficient antioxidant defenses exacerbate this effect by failing to counterbalance oxidative injury, thereby perpetuating a vicious cycle of cellular stress and sleep disturbance. These findings suggest potential avenues for intervention, emphasizing the importance of modulating systemic inflammation and enhancing antioxidant capacity as strategies to improve sleep quality in aging populations.

Liu and colleagues employed rigorous quantitative assays to quantify serum cytokines and TAC in a large cohort of elderly subjects, complementing these biochemical analyses with detailed polysomnographic evaluations and subjective sleep questionnaires.

By identifying serum inflammatory markers and antioxidant capacity as measurable, modifiable factors intimately linked with sleep outcomes, the study opens the door to novel diagnostic biomarkers and targeted interventions that could revolutionize geriatric sleep medicine. The biochemical signatures identified could serve as critical endpoints in clinical trials investigating anti-inflammatory or antioxidant therapies aimed at mitigating sleep disturbances and associated cognitive decline.